05/13/2026
What if there was a peptide being researched for its potential to help support the body’s natural repair systems—without acting like a traditional hormone?
Meet ARA-290.
ARA-290 is a synthetic peptide derived from erythropoietin (EPO), but unlike EPO, it does not significantly stimulate red blood cell production. Instead, researchers are studying it for its potential effects on:
✅ Neuroinflammation
✅ Nerve repair and regeneration
✅ Neuropathic discomfort
✅ Cellular recovery
✅ Mitochondrial and tissue protection
Researchers believe ARA-290 works by activating something called the Innate Repair Receptor (IRR) — a pathway involved in the body’s response to injury and inflammation.
Why is this important?
Chronic inflammation and nerve dysfunction are increasingly being linked to:
• Peripheral neuropathy
• Metabolic dysfunction
• Chronic pain states
• Autonomic imbalance
• Age-related decline in recovery
Although early research is promising, it’s important to understand:
⚠️ ARA-290 is still considered investigational and is not FDA-approved for general treatment purposes.
⚠️ Human research is ongoing.
⚠️ More long-term safety and efficacy data are needed.
At Next Level TRT, we believe education matters. The future of longevity medicine is moving toward therapies that focus not only on symptom management—but also on recovery, resilience, and optimization at the cellular level.
📍Burleson, Texas
📞 866-656-5878
🌐 TX & NE telemedicine available
